Association of high sensitivity C-reactive protein and metabolic syndrome components in middle-aged subjects without overt cardiovascular disease in LitHiR primary prevention programme-Reference-Cited by-同舟云学术

Association of high sensitivity C-reactive protein and metabolic syndrome components in middle-aged subjects without overt cardiovascular disease in LitHiR primary prevention programme

Published:2020-01-01 Issue:1 Volume:26 Page:14-19
ISSN:1822-7767
Container-title:Seminars in Cardiovascular Medicine
language:en
Short-container-title:

Author:

Saulė Ieva Marija¹,Mikolaitytė Jurgita²,Badarienė Jolita³,Zupkauskienė Jūratė³,Puronaitė Roma¹⁴⁵,Čypienė Alma²³,Laucevičius Aleksandras²³

Affiliation:

1. Vilnius University , Faculty of Medicine , Vilnius , Lithuania

2. State Research Institute Centre for Innovative Medicine , Vilnius , Lithuania

3. Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine , Faculty of Medicine , Vilnius University , Vilnius , Lithuania

4. Centre of Informatics and Development , Vilnius University , Vilnius , Lithuania

5. Vilnius University Faculty of Mathematics and Informatics , Institute of Data Science and Digital Technologies , Vilnius , Lithuania

Abstract

Summary Objectives: Circulating levels of inflammatory markers such as high sensitivity C-reactive protein (hs-CRP) have been reported to be associated with increased risk of cardiovascular disease (CVD), as well as with metabolic syndrome (MetS). Therefore, our objectives were to investigate the associations between hs-CRP levels and individual MetS components as well as to analyse if hs-CRP levels are linked with the number of MetS components present in middle-aged subjects. Design and methods: A cross-sectional study included 4628 middle-aged MetS subjects from the Lithuanian High Cardiovascular Risk primary prevention programme (LitHiR) from 2011 to 2020. MetS was diagnosed according to the National Cholesterol Education Program ATP III modified criteria. CRP was measured by a validated high-sensitivity assay. A hs-CRP cutpoint of 5 mg/l was used to differentiate high and low hs-CRP groups. Results: The mean value of hs-CRP was 3.23 ± 4.04 mg/l, and significantly increased as the number of components of MetS increased (p < 0.001). The concentration of serum hs-CRP was significantly associated with waist circumference, systolic and diastolic blood pressure, and fasting blood glucose (all p < 0.001). However, no statistically significant associations were found between hs-CRP and serum triglycerides (p = 0.340) or serum high-density lipoprotein cholesterol (p = 0.148). Conclusions: Serum hs-CRP increased progressively with increased waist circumference, blood pressure, fasting blood glucose in middle-aged subjects with MetS. The higher values of hs-CRP were more often present in obese subjects and women. The incremental rise in mean serum hs-CRP level was found with an increasing number of MetS components.

Publisher

Walter de Gruyter GmbH

Link

https://www.sciendo.com/pdf/10.2478/semcard-2020-0003

Reference28 articles.

1. [1] Wang J, Tan G-J, Han L-N, Bai Y-Y, He M, Liu H-B. Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol JGC 2017;14(2):135–50.

2. [2] Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367(14):1310–20.

3. [3] Li Y, Zhong X, Cheng G, Zhao C, Zhang L, Hong Y, et al. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis. Atherosclerosis 2017;259:75–82.

4. [4] Shah PK, Lecis D. Inflammation in atherosclerotic cardiovascular disease. F1000Res 2019;8:F1000 Faculty Rev-1402.

5. [5] Wu M-Y, Li C-J, Hou M-F, Chu P-Y. New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int J Mol Sci 2017;18(10):2034.